More than that, many types of mutant p53 (mut-p53) have been widely reported to acquire novel tumor-promoting phenotypes opposed to the wild-type p53 (wt-p53) via transcription- or non-transcription-dependent mechanisms, termed “Gain-of-Function” (GOF) [21]. Here, TP53 is linked to neoplasm.